Building comparative efficacy and tolerability into the FDA approval process

JAMA. 2010 Mar 10;303(10):979-80. doi: 10.1001/jama.2010.257.

Author

Alec B O'Connor¹

Affiliation

¹ University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. alec_oconnor@urmc.rochester.edu

PMID: 20215612
DOI: 10.1001/jama.2010.257

No abstract available

MeSH terms

Comparative Effectiveness Research*
Device Approval / standards*
Drug Approval / organization & administration*
Product Labeling
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration*